Differences Between Sweden and Greece in Joint Outcomes Assessed by Ultrasound in Adolescents With Severe Haemophilia on Prophylaxis: Data From the PedNet Registry

Documenti analoghi

• Bleeding control improves after switching to emicizumab: Real‐world experience of 177 children in the PedNet registry
  di: Konrad van der Zwet, et al.
  Pubblicazione: (2024)
• Blood Group O Does Not Increase the Risk of Inhibitors in Severe Haemophilia A: Data from the PedNet Study Group
  di: Marloes de Kovel, et al.
  Pubblicazione: (2025)
• Impact of Family History of Haemophilia on Diagnosis, Management and Outcomes in Severe Haemophilia
  di: Ana Mendoza, et al.
  Pubblicazione: (2025)
• Muscle Strength in Children and Adolescents With Haemophilia on Prophylaxis: An Age‐Adjusted Dynamometric Study
  di: Dimitrios Syrengelas, et al.
  Pubblicazione: (2026)
• Outcomes of Emicizumab Treatment for Haemophilia A Paediatric Patients: A Systematic Review With Meta‐Analysis
  di: Konstantina Bolou, et al.
  Pubblicazione: (2025)